Pharmacoepidemiological evaluation in prostate cancer: common pitfalls and how to avoid them

Tutkimustuotos: Review ArticleScientificvertaisarvioitu

1 Sitaatiot (Scopus)


Pharmacoepidemiologic research provides opportunities to evaluate how commonly used drug groups, such as cholesterol-lowering or antidiabetic drugs, may affect the prostate cancer risk or mortality. This type of research is valuable in estimating real-life drug effects. Nonetheless, pharmacoepidemiological studies are prone to multiple sources of bias that mainly arise from systematic differences between medication users and non-users. If these are not appreciated and properly controlled for, there is a risk of obtaining biased results and reaching erroneous conclusions. Therefore, in order to improve the quality of future research, we describe common biases in pharmacoepidemiological studies, particularly in the context of prostate cancer research. We also list common ways to mitigate these biases and to estimate causality between medication use and cancer outcomes.

DOI - pysyväislinkit
TilaJulkaistu - 2021
OKM-julkaisutyyppiA2 Katsausartikkeli


  • Jufo-taso 1

!!ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Sukella tutkimusaiheisiin 'Pharmacoepidemiological evaluation in prostate cancer: common pitfalls and how to avoid them'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.

Siteeraa tätä